본문 바로가기
KERD
논문KCI 등재

주요공존장애를 동반하는 주의력결핍 과잉행동장애의 임상 진료지침

Clinical Practice Guidelines for Major Comorbid Disorders with Attention-Deficit Hyperactivity Disorder

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류정신과학

초록

Attention-deficit hyperactivity disorder (ADHD) occurs with a high prevalence of comorbid disorders, and these comorbid disorders can affect assessment, clinical symptoms, prognosis, and treatment strategies for children with ADHD. The goal of this study was to develop a clinical practice guideline for ADHD and its specific comorbid disorders. Due to limited numbers of previous clinical studies, current recommendations are based on literature review and expert consensus among Korean child and adolescent psychiatrists. We suggest the use of multidisciplinary evaluations, interview techniques, and assessment tools in order to differentiate major comorbid disorders from ADHD. Specific ADHD comorbid disorders (e.g., medical comorbidity, oppositional defiant disorder, conduct disorder, bipolar disorder, major depressive disorder, anxiety disorder, specific learning disorder, tic disorder, and substance use disorder) have suggested treatment protocols that include pharmacological and behavioral treatments. Children and adolescents with ADHD may have comorbid disorders. The use of current clinical practice guidelines will be helpful when treating ADHD children with comorbid disorders.

Abstract

Attention-deficit hyperactivity disorder (ADHD) occurs with a high prevalence of comorbid disorders, and these comorbid disorders can affect assessment, clinical symptoms, prognosis, and treatment strategies for children with ADHD. The goal of this study was to develop a clinical practice guideline for ADHD and its specific comorbid disorders. Due to limited numbers of previous clinical studies, current recommendations are based on literature review and expert consensus among Korean child and adolescent psychiatrists. We suggest the use of multidisciplinary evaluations, interview techniques, and assessment tools in order to differentiate major comorbid disorders from ADHD. Specific ADHD comorbid disorders (e.g., medical comorbidity, oppositional defiant disorder, conduct disorder, bipolar disorder, major depressive disorder, anxiety disorder, specific learning disorder, tic disorder, and substance use disorder) have suggested treatment protocols that include pharmacological and behavioral treatments. Children and adolescents with ADHD may have comorbid disorders. The use of current clinical practice guidelines will be helpful when treating ADHD children with comorbid disorders.

참고문헌 (104)

  1. Jameson ND, "Medical comorbidity of attention-deficit", hyperactivity disorder in US adolescents, 2016, pp.31, 1282~1289
  2. Cuffe SP, "ADHD and psychiatric comorbidity: functional outcomes in a school-based sample of children", J Atten Disord (2015)
  3. Kessler RC, "The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication", Am J Psychiatry, 163, pp.716~723 (2006)
  4. Yoon Huh, "A Comparison of Comorbidity and Psychological Outcomes in Children and Adolescents with Attention-Deficit", Hyperactivity Disorder, 2011, pp.8(2), 95~101[DOI]
  5. Pliszka S, "Practice parameter for the assessment and treatment of children and adolescents with attention-deficit", hyperactivity disorder, 2007, pp.46, 894~921
  6. Efron D, "Children referred for evaluation for ADHD: comorbidity profiles and characteristics associated with a positive diagnosis", Child Care Health Dev, 42, pp.718~724 (2016)
  7. Korean Academy of Child and Adolescents Psychiatry, "Adolescent Psychiatry", pp.90~103 (2012), Sigmapress
  8. Shaffer D, "NIMH Diagnostic Interview Schedule for Children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses", J Am Acad Child Adolesc Psychiatry, 39, pp.28~38 (2000)
  9. 조수철, "한국어판 DISC-IV(Diagnostic Interview Schedule for Children Version IV)의 신뢰도 및 타당도", 소아 청소년 정신의학, 18(2), pp.138~144 (2007), 대한소아청소년 정신의학회
  10. Endicott J, "A diagnostic interview: the schedule for affective disorders and schizophrenia", Arch Gen Psychiatry, 35, pp.837~844 (1978)
  11. 김영신, "The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean Version (K-SADS-PL-K)", Yonsei Medical Journal, 45(1), pp.81~89 (2004), 연세대학교의과대학
  12. Oh K, "Korean version of child behavior checklist (K-CBCL)" (1997), Chung Ang Aptitude Publishing Co
  13. 조선미, "한국 아동 인성 평정 척도(Korean Personality Rating Scale for Children; KPRC)의 표준화 연구", Korean Journal of Clinical Psychology, 25(3), pp.825~848 (2006), 한국임상심리학회
  14. 이영식, "Attention Deficit Hyperactivity Disorder Like Behavioral Problems and Parenting Stress in Pediatric Allergic Rhinitis", PSYCHIATRY INVESTIGATION, 11(3), pp.266~271 (2014), 대한신경정신의학회[DOI]
  15. Lahey BB, "Predicting future antisocial personality disorder in males from a clinical assessment in childhood", J Consult Clin Psychol, 73, pp.389~399 (2005)
  16. Harpold T, "Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD", J Nerv Ment Dis, 195, pp.601~605 (2007)
  17. Steinhoff KW, "Special issues in the diagnosis and treatment of ADHD in adolescents", Postgrad Med, 120, pp.60~68 (2008)
  18. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders (DSM-5)" (2013), American Psychiatric Association
  19. Danforth JS, "The outcome of group parent training for families of children with attention-deficit hyperactivity disorder and defiant", aggressive behavior, 2006, pp.37, 188~205
  20. Kazdin AE, "Parent management training: evidence, outcomes, and issues", J Am Acad Child Adolesc Psychiatry, 36, pp.1349~1356 (1997)
  21. Spencer TJ, "Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit", hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study, 2006, pp.28, 402~418
  22. Garg J, "Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder", Int J Appl Basic Med Res, 5, pp.114~118 (2015)
  23. Newcorn JH, "Atomoxetine treatment in children and adolescents with attentiondeficit", hyperactivity disorder and comorbid oppositional defiant disorder, 2005, pp.44, 240~248
  24. Bangs ME, "Atomoxetine for the treatment of attention-deficit", hyperactivity disorder and oppositional defiant disorder, 2008, pp.121, e314~e320
  25. Palumbo DR, "Clonidine for attention-deficit", hyperactivity disorder:I. Efficacy and tolerability outcomes, 2008, pp.47, 180~188
  26. Connor DF, "A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder", Clin Pediatr (Phila), 39, pp.15~25 (2000)
  27. Biederman J, "Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders", Am J Psychiatry, 148, pp.564~577 (1991)
  28. van Lieshout M, "A 6-year follow-up of a large European cohort of children with attention-deficit", hyperactivity disorder-combined subtype:outcomes in late adolescence and young adulthood, 2016, pp.25, 1007~1017
  29. Mannuzza S, "Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records", Psychiatry Res, 160, pp.237~246 (2008)
  30. Barkley RA, "Attention-deficit hyperactivity disorder", Sci Am, 279, pp.66~71 (1998)
  31. Biederman J, "Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD", J Am Acad Child Adolesc Psychiatry, 35, pp.1193~1204 (1996)
  32. Kutcher S, "International consensus statement on attention-deficit", hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs):clinical implications and treatment practice suggestions, 2004, pp.14, 11~28
  33. MTA Cooperative Group, "National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment", Pediatrics, 113, pp.762~769 (2004)
  34. Klein RG, "Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder", Arch Gen Psychiatry, 54, pp.1073~1080 (1997)
  35. Connor DF, "Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt", covert aggression-related behaviors in ADHD, 2002, pp.41, 253~261
  36. Pliszka SR, "Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management", Paediatr Drugs, 5, pp.741~750 (2003)
  37. Pringsheim T, "The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder:a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers", Can J Psychiatry, 60, pp.52~61 (2015)
  38. Aman MG, "What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit", hyperactivity disorder, 2014, pp.53, 47~60
  39. Armenteros JL, "Risperidone augmentation for treatment-resistant aggression in attention-deficit", hyperactivity disorder: a placebo-controlled pilot study, 2007, pp.46, 558~565
  40. Snyder R, "Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs", J Am Acad Child Adolesc Psychiatry, 41, pp.1026~1036 (2002)
  41. Malone RP, "A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder", Arch Gen Psychiatry, 57, pp.649~654 (2000)
  42. Donovan SJ, "Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design", Am J Psychiatry, 157, pp.818~820 (2000)
  43. Biederman J, "Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity", Am J Psychiatry, 152, pp.1652~1658 (1995)
  44. Diler RS, "Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder", J Affect Disord, 102, pp.125~130 (2007)
  45. Biederman J, "Depression in attention deficit hyperactivity disorder (ADHD) children: “true” depression or demoralization", J Affect Disord, 47, pp.113~122 (1998)
  46. Bushe CJ, "Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a metaanalysis of atomoxetine and methylphenidate comparator clinical trials", Child Adolesc Psychiatry Ment Health, 7, pp.19~ (2013)
  47. Agosti V, "Does attention deficit hyperactivity disorder increase the risk of suicide attempts", J Affect Disord, 133, pp.595~599 (2011)
  48. Bond DJ, "The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attentiondeficit", hyperactivity disorder, 2012, pp.24, 23~37
  49. Atomoxetine ADHD, "Efficacy and safety of atomoxetine in adolescents with attention-deficit", hyperactivity disorder and major depression, 2007, pp.17, 407~420
  50. Hughes CW, "Texas Children’s Medication Algorithm Project: update from Texas consensus conference panel on medication treatment of childhood major depressive disorder", J Am Acad Child Adolesc Psychiatry, 46, pp.667~686 (2007)
  51. Kratochvil CJ, "Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms", J Am Acad Child Adolesc Psychiatry, 44, pp.915~924 (2005)
  52. Gammon GD, "Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder", J Child Adolesc Psychopharmacol, 3, pp.1~10 (1993)
  53. Wagner KD, "Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials", JAMA, 290, pp.1033~1041 (2003)
  54. Emslie GJ, "Mood disorders in children and adolescents:psychopharmacological treatment", Biol Psychiatry, 49, pp.1082~1090 (2001)
  55. Daviss WB, "Bupropion sustained release in adolescents with comorbid attention-deficit", hyperactivity disorder and depression, 2001, pp.40, 307~314
  56. Kratochvil CJ, "Treatment response in depressed adolescents with and without co-morbid attention-deficit", hyperactivity disorder in the Treatment for Adolescents with Depression Study, 2009, pp.19, 519~527
  57. "A 14-month randomized clinical trial of treatment strategies for attention-deficit", hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD, 1999, pp.56, 1073~1086
  58. West SA, "McConville BJ. Attention deficit hyperactivity disorder in adolescent mania", Am J Psychiatry, 152, pp.271~273 (1995)
  59. Biederman J, "Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity", J Am Acad Child Adolesc Psychiatry, 35, pp.997~1008 (1996)
  60. Milberger S, "Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms", Am J Psychiatry, 152, pp.1793~1799 (1995)
  61. Donfrancesco R, "Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder", Psychiatry Res, 186, pp.333~337 (2011)
  62. 정희연, "Young조증 평가 척도의 한국판 표준화 연구", 신경정신의학, 42(2) (2003), 대한신경정신의학회
  63. 천근아, "한국판 소아 양극성장애 설문지 2.0(Child Bipolar Questionnaire 2.0)의 신뢰도 및 타당도 연구", 신경정신의학, 47(3), pp.269~278 (2008), 대한신경정신의학회
  64. 전덕인, "한국형 기분장애 질문지의 타당화 연구", 신경정신의학, 44(5), pp.583~590 (2005), 대한신경정신의학회
  65. Consoli A, "Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a metaanalysis", Can J Psychiatry, 52, pp.323~328 (2007)
  66. Biederman J, "The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review", J Clin Psychiatry, 59, pp.628~637 (1998)
  67. DelBello MP, "Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset", Bipolar Disord, 3, pp.53~57 (2001)
  68. Carlson GA, "Stimulant treatment in young boys with symptoms suggesting childhood mania:a report from a longitudinal study", J Child Adolesc Psychopharmacol, 10, pp.175~184 (2000)
  69. Liu HY, "Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis", J Am Acad Child Adolesc Psychiatry, 50, pp.749~762 (2011)
  70. Carlson GA, "The effects of methylphenidate and lithium on attention and activity level", J Am Acad Child Adolesc Psychiatry, 31, pp.262~270 (1992)
  71. Jensen PS, "ADHD comorbidity findings from the MTA study:comparing comorbid subgroups", J Am Acad Child Adolesc Psychiatry, 40, pp.147~158 (2001)
  72. 변희정, "Psychiatric Comorbidity in Korean Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Psychopathology According to Subtype", Yonsei Medical Journal, 47(1), pp.113~121 (2006), 연세대학교의과대학
  73. Ter-Stepanian M, "Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders", Can J Psychiatry, 55, pp.305~312 (2010)
  74. Goez H, "Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder", J Child Neurol, 22, pp.538~542 (2007)
  75. Barkley RA, "Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation", Pediatrics, 86, pp.184~192 (1990)
  76. Diamond IR, "Response to methylphenidate in children with ADHD and comorbid anxiety", J Am Acad Child Adolesc Psychiatry, 38, pp.402~409 (1999)
  77. Geller D, "Atomoxetine treatment for pediatric patients with attention-deficit", hyperactivity disorder with comorbid anxiety disorder, 2007, pp.46, 1119~1127
  78. Snircova E, "Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD", Pediatr Int, 58, pp.476~481 (2016)
  79. Pliszka SR, "The Texas Children’s Medication Algorithm Project:revision of the algorithm for pharmacotherapy of attention-deficit", hyperactivity disorder, 2006, pp.45, 642~657
  80. March JS, "Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)", J Abnorm Child Psychol, 28, pp.527~541 (2000)
  81. Sciberras E, "Managing anxiety in children with ADHD using cognitive-behavioral therapy: a pilot randomized controlled trial", J Atten Disord (2015)
  82. Maric M, "Parental involvement in CBT for anxiety-disordered youth revisited: family CBT outperforms child CBT in the long term for children with comorbid ADHD symptoms", J Atten Disord (2015)
  83. Klein RG, "Clinical and functional outcome of childhood attention-deficit", hyperactivity disorder 33 years later, 2012, pp.69, 1295~1303
  84. Cao F, "Deficient orthographic and phonological representations in children with dyslexia revealed by brain activation patterns", J Child Psychol Psychiatry, 47, pp.1041~1050 (2006)
  85. Richlan F, "Developmental dyslexia: dysfunction of a left hemisphere reading network", Front Hum Neurosci, 6, pp.120~ (2012)
  86. 유한익, "국내 아동 및 청소년 난독증 진단을 위한 종합학습능력평가도구 -읽기의 표준화 연구", 소아 청소년 정신의학, 27(2), pp.109~118 (2016), 대한소아청소년 정신의학회
  87. Jung JS, "Comprehensive literacy program for Korean dyslexics" (2014), Goodteacher
  88. Shaywitz BA, "Development of left occipitotemporal systems for skilled reading in children after a phonologically- based intervention", Biol Psychiatry, 55, pp.926~933 (2004)
  89. Keulers EH, "Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial", Eur J Paediatr Neurol, 11, pp.21~28 (2007)
  90. Grizenko N, "Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial", J Psychiatry Neurosci, 31, pp.46~51 (2006)
  91. Wietecha L, "Atomoxetine improved attention in children and adolescents with attention-deficit", hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial, 2013, pp.23, 605~613
  92. Rothenberger A, "Co-existence of tic disorders and attention-deficit", hyperactivity disorderrecent advances in understanding and treatment, 2007, pp.16(Suppl 1), 1~4
  93. Leckman JF, "The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity", J Am Acad Child Adolesc Psychiatry, 28, pp.566~573 (1989)
  94. Chung SJ, "Development of the Korean Form of Yale Global Tic Severity Scale: a validity and reliability study", J Korean Neuropsychiatr Assoc, 37, pp.942~951 (1998)
  95. Cohen SC, "Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials", J Am Acad Child Adolesc Psychiatry, 54, pp.728~736 (2015)
  96. Bloch MH, "Metaanalysis:treatment of attention-deficit", hyperactivity disorder in children with comorbid tic disorders, 2009, pp.48, 884~893
  97. Lee SS, "Prospective association of childhood attention-deficit", hyperactivity disorder (ADHD) and substance use and abuse, Clin Psychol Rev, pp.2011, 31[DOI]
  98. Wilens TE, "Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD", J Am Acad Child Adolesc Psychiatry, 50, pp.543~553 (2011)
  99. Knecht C, "Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions", Int J Adolesc Med Health, 27, pp.163~175 (2015)
  100. Yoo HJ, "Attention deficit hyperactivity symptoms and internet addiction", Psychiatry Clin Neurosci, 58, pp.487~494 (2004)
  101. Bae S, "Neurochemical correlates of internet game play in adolescents with attention deficit hyperactivity disorder: a proton magnetic resonance spectroscopy (MRS) study", Psychiatry Res, 254, pp.10~17 (2016)
  102. Han DH, "Brain connectivity and psychiatric comorbidity in adolescents with internet gaming disorder", Addict Biol (2015)
  103. Yen CF, "The association of internet addiction symptoms with anxiety, depression and self-esteem among adolescents with attention-deficit", hyperactivity disorder, 2014, pp.55, 1601~1608
  104. Han DH, "The effect of methylphenidate on internet video game play in children with attention-deficit", hyperactivity disorder, 2009, pp.50, 251~256

관련 논문AI추천

이 간행물의 다른 논문 (19건)